BamSEC and AlphaSense Join Forces
Learn More

Cancer Prevention Pharmaceuticals, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.35
from S-1/A 13 pages Master Services Agreement
12/34/56
EX-10.34
from S-1/A 11 pages Cancer Prevention Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan Adopted by the Board of Directors: January 29, 2016 Approved by the Stockholders: January 29, 2016
12/34/56
EX-10.33
from S-1/A 13 pages Employment Agreement
12/34/56
EX-10.32
from S-1/A 13 pages Employment Agreement
12/34/56
EX-10.31
from S-1/A 28 pages Option and Collaboration Agreement
12/34/56
EX-10.30
from S-1/A 29 pages Securities Purchase Agreement
12/34/56
EX-10.29
from S-1/A 11 pages Form of Note and Warrant Purchase Agreement
12/34/56
EX-10.28
from S-1 4 pages First Amendment to the Exclusive License Agreement Between the Arizona Board of Regents on Behalf of the University of Arizona and Cancer Prevention Pharmaceuticals Inc. University of Arizona File(s) Ua98-023
12/34/56
EX-10.27
from S-1 18 pages Amended and Restated Exclusive License Agreement Between the Arizona Board of Regents on Behalf of the University of Arizona and Cancer Prevention Pharmaceuticals, Inc
12/34/56
EX-10.26
from S-1 23 pages Portions Herein Identified by [*****] Have Been Omitted Pursuant to a Request for Confidential Treatment Under Rule 406 of the Securities Act of 1933, as Amended. a Complete Copy of This Document Has Been Filed Separately With the Securities and Exchange Commission
12/34/56
EX-10.25
from S-1 5 pages Assignment, Assumption & Second Amendment to Product Manufacturing & Supply Agreement
12/34/56
EX-10.24
from S-1 2 pages First Amendment to the Product Manufacturing & Supply Agreement
12/34/56
EX-10.23
from S-1 49 pages Product Manufacturing & Supply Agreement
12/34/56
EX-10.22
from S-1 9 pages Agreement S0820 – Cancer Prevention Pharmaceuticals, Inc
12/34/56
EX-10.21
from S-1 1 page Amendment No. 1 to Pharmaceutical Product Co-Development and License Agreement
12/34/56
EX-10.20
from S-1 97 pages Pharmaceutical Product Co-Development and License Agreement Between Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG December 27, 2013
12/34/56
EX-10.19
from S-1 27 pages Section 1 Authorization, Sale and Issuance
12/34/56
EX-10.18
from S-1 27 pages Cancer Prevention Pharmaceuticals, Inc. Series A-2 Preferred Stock Purchase Agreement November 19, 2012 Cancer Prevention Pharmaceuticals, Inc. Series A-2 Preferred Stock Purchase Agreement
12/34/56
EX-10.17
from S-1 3 pages Cancer Prevention Pharmaceuticals, Inc. Amendment to Right of First Refusal and Co-Sale Agreement
12/34/56
EX-10.16
from S-1 14 pages Agreements
12/34/56